The global bowel management systems market size was valued at USD 1.8 billion in 2025 and is projected to grow from USD 1.9 billion in 2026 to USD 2.4 billion in 2033, at a CAGR of 3.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 36.0% in 2025. This growth is attributed to the increasing prevalence of bowel-related disorders and conditions, such as inflammatory bowel disease, fecal incontinence, and colorectal cancer. In addition, the growing geriatric population, who are more susceptible to bowel dysfunction, is also contributing to market growth. Furthermore, technological advancements in bowel management devices, including improved irrigation systems, ostomy bags, and nerve modulation devices, enable more effective treatment options and drive adoption.
Bowel management is a significant and often time-consuming issue for an increasing number of patients with spinal cord injury. However, worldwide, the elderly population is the fastest-growing segment, leading to severe problems. Children with spina bifida often face bowel-related challenges, such as constipation and incontinence, due to various factors. Neurological abnormalities associated with the condition can lead to a lack of bowel control, weak abdominal muscles, and reduced physical activity. Furthermore, dietary factors, including insufficient fiber intake, contribute to constipation. As these individuals grow older, they may experience age-related changes in bowel function, which can exacerbate existing issues or introduce new complications.
In addition, these are temporary containment devices designated for disabled or immobilized incontinent patients with less or no bowel control, having a liquid or semi-liquid stool, and persistent diarrhea. In addition, the increasing geriatric population, growth in target patient volumes, rising rates of gastrointestinal diseases and pelvic floor dysfunction, and the accessibility of technologically enhanced bowel management systems, coupled with favorable reimbursement conditions in various countries, drive market growth. For instance, in September 2025, a leading medical device company, such as Coloplast Group, strengthened its long-term strategy to expand its continence and chronic care solutions, reflecting rising global demand for bowel management and related patient care systems.
Furthermore, the growing elderly population increases demand for efficient bowel management. The management preferences include oral and/or anal medication, digital stimulation, or manual evacuation; hence, the rising prevalence of fecal incontinence, pelvic floor dysfunctions, and age-related muscle weaknesses results in market growth for the bowel management system market across the world.
Global Bowel Management Systems Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bowel management systems market report based on type, patient type, end use, and region:
- Type Outlook (Revenue, USD Billion, 2021 - 2033)
Colostomy Bags
Irrigation Systems
Nerve Modulation Devices
Others
- Patient Type Outlook (Revenue, USD Billion, 2021 - 2033)
Adult
Pediatric
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
Home Care
Hospitals and Ambulatory Surgery Centers
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Bowel Management Systems Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Bowel Management Systems Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
Chapter 4. Bowel Management Systems Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Bowel Management Systems Market: Type Movement Analysis, 2025 & 2033 (USD Million)
- 4.3. Colostomy Bags
- 4.3.1. Colostomy Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Irrigation Systems
- 4.4.1. Irrigation Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Nerve Modulation Devices
- 4.5.1. Nerve Modulation Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Bowel Management Systems Market: Patient Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Bowel Management Systems Market: Patient Type Movement Analysis, 2025 & 2033 (USD Million)
- 5.3. Adult
- 5.3.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Pediatric
- 5.4.1. Pediatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Bowel Management Systems Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Bowel Management Systems Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
- 6.3. Home Care
- 6.3.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Hospitals and Ambulatory Surgery Centers
- 6.4.1. Hospitals and Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Bowel Management Systems Market: Regional Estimates & Trend Analysis
- 7.1. Bowel Management Systems Market Share, By Region, 2025 & 2033, USD Million
- 7.2. North America
- 7.2.1. North America Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Canada Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Mexico Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. UK
- 7.3.2.1. UK Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Germany Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. France
- 7.3.4.1. France Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Italy Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Spain Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Denmark Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Sweden Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Norway Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. China
- 7.4.2.1. China Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Japan Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. India
- 7.4.4.1. India Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. South Korea Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Australia Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Thailand Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Brazil Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Argentina Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. South Africa Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Saudi Arabia Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. UAE Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Kuwait Bowel Management Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.4.1. Convatec Inc.
- 8.4.1.1. Participant's Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. BD
- 8.4.2.1. Participant's Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. ProSys International Ltd
- 8.4.3.1. Participant's Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Suzhou Shenyun Medical Equipment Co., Ltd
- 8.4.4.1. Participant's Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Coloplast Corp
- 8.4.5.1. Participant's Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Consure Medical
- 8.4.6.1. Participant's Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Axonics, Inc.
- 8.4.7.1. Participant's Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. SAYCO PTY LTD
- 8.4.8.1. Participant's Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Qufora
- 8.4.9.1. Participant's Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Hollister Incorporated
- 8.4.10.1. Participant's Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Recent Developments/ Strategic Initiatives
- 8.4.11. Wellspect HealthCare, a Dentsply Sirona Company.
- 8.4.11.1. Participant's Overview
- 8.4.11.2. Financial Performance
- 8.4.11.3. Product Benchmarking
- 8.4.11.4. Recent Developments/ Strategic Initiatives
- 8.4.12. Welland Medical Limited.
- 8.4.12.1. Participant's Overview
- 8.4.12.2. Financial Performance
- 8.4.12.3. Product Benchmarking
- 8.4.12.4. Recent Developments/ Strategic Initiatives